Erschienen in:
01.11.2011 | Original Article
Bleeding and Thromboembolic Outcomes for Patients on Oral Anticoagulation Undergoing Elective Colon and Rectal Abdominal Operations
verfasst von:
Corey W. Iqbal, Robert R. Cima, John H. Pemberton
Erschienen in:
Journal of Gastrointestinal Surgery
|
Ausgabe 11/2011
Einloggen, um Zugang zu erhalten
Abstract
Purpose
Patients on chronic oral anticoagulation can be challenging to manage in the perioperative period.
Methods
Review of patients on warfarin undergoing elective abdominal colon and rectal operations at a single institution from 2000 to 2006.
Results
One forty-six patients underwent 165 abdominal procedures. Mean (±SEM) age was 67 ± 1 years; 59% of patients were men. Median estimated blood loss was 200 ml, and 19% received intraoperative blood products while 19% of patients received a postoperative transfusion. Sixteen patients (10%) experienced bleeding complications (three requiring reoperation). No risk factors for bleeding were identified by multivariate analysis (MVA). Five patients (3%) suffered a postoperative thromboembolic event. Preoperative anticoagulation for cerebrovascular disease was a risk factor for thromboembolism (p = 0.03). Overall operative morbidity was 30% with no identifiable risk factor in MVA. Mortality was nil.
Conclusion
Postoperative bleeding and thromboembolism in patients on chronic anticoagulation are not insignificant (10% and 3%, respectively). Patients on warfarin for cerebrovascular disease are at increased risk for thromboembolic events postoperatively and should be placed on appropriate prophylaxis and monitored.